INT154420

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 4
Disease Relevance 0.49
Pain Relevance 0.15

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (Cdan1) cellular_component (Cdan1)
Cdan1 (Mus musculus)
Pain Link Frequency Relevance Heat
methotrexate 48 98.08 Very High Very High Very High
Inflammatory marker 33 76.72 Quite High
rheumatoid arthritis 59 50.00 Quite Low
Pain 4 50.00 Quite Low
Arthritis 6 29.96 Quite Low
corticosteroid 12 5.00 Very Low Very Low Very Low
cINOD 9 5.00 Very Low Very Low Very Low
fibrosis 3 5.00 Very Low Very Low Very Low
Inflammation 3 5.00 Very Low Very Low Very Low
alcohol 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pressure And Volume Under Development 9 84.32 Quite High
INFLAMMATION 39 76.72 Quite High
Rheumatoid Arthritis 60 62.72 Quite High
Disease 56 58.72 Quite High
Arthropathy 9 50.00 Quite Low
Pain 4 50.00 Quite Low
Arthritis 3 29.96 Quite Low
Hepatitis 6 5.00 Very Low Very Low Very Low
Infection 6 5.00 Very Low Very Low Very Low
Pulmonary Fibrosis 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Regression analysis revealed a highly significant relationship between SDAI/CDAI levels and patient's pain rating (SDAI: r = 0.660, p<0.001; CDAI: r = 0.671, p<0.001).
Negative_regulation (relationship) of Gene_expression (levels) of SDAI/CDAI
1) Confidence 0.05 Published 2008 Journal Scand. J. Rheumatol. Section Body Doc Link 18759162 Disease Relevance 0.18 Pain Relevance 0
In the control (TCZ placebo plus MTX 8 mg/week) group, only one patient (1.6%) achieved even DAS28-ESR remission; this patient also achieved CDAI and SDAI remission.
Negative_regulation (achieved) of Gene_expression (remission) of CDAI associated with methotrexate
2) Confidence 0.03 Published 2010 Journal Mod Rheumatol Section Body Doc Link PMC2999727 Disease Relevance 0.07 Pain Relevance 0.05
A difference between DAS28-ESR and CDAI or SDAI remission among ACR response rates was also observed.
Negative_regulation (difference) of Gene_expression (remission) of CDAI
3) Confidence 0.03 Published 2010 Journal Mod Rheumatol Section Body Doc Link PMC2999727 Disease Relevance 0.15 Pain Relevance 0.08
Among the 17 patients who were in DAS28 remission but not CDAI remission, six patients (35.3%) had a SJC ?
Negative_regulation (were) of Gene_expression (remission) of CDAI
4) Confidence 0.03 Published 2010 Journal Mod Rheumatol Section Body Doc Link PMC2999727 Disease Relevance 0.08 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox